Introduction

We have about 10 000 bacterial species in hand but numerous numbers of organisms have eluded laboratory cultivations. Why do most bacteria refuse to grow on laboratory media? This is a profound question many microbiologists and chemists have been trying to answer for a century.1 To date, several bacteria are known to require growth-promoting factors or specific diffusible components supplied by a neighbor or partner bacterium in the same environment.2, 3, 4, 5, 6, 7, 8, 9, 10 In our previous studies, we found that the supernatant of Sphingopyxis sp. GF9 isolated from an activated sludge significantly stimulated the growth of uncultured bacteria or bacterial organisms, which otherwise grew very poorly, including Catellibacterium nectariphilum AST4T within the class alpha-Proteobacteria.4, 11

Here, we report novel porphyrin-type growth factors produced by strain GF9 that induce significant proliferation of a previously uncultured (here referred to as ‘uncultured’) actinobacterial strain, Leucobacter sp. ASN212, at picomolar to nanomolar levels. Even more surprisingly, the ASN212 growth factors showed self-toxicities against the growth-factor-producing bacterium, strain GF9, at picomolar to nanomolar concentrations. Co-culture experiments of strain GF9 with strain ASN212 indicated that strain ASN212 helps the survival of strain GF9 in the long-term culture. These findings imply another aspect of these growth factors to maintain a primitive mutualism existing in the bacterial consortium.

Figure 1 illustrates a growth-factor transfer network and prospective role of the ASN212 growth factors investigated in the present work. The results of this study imply that these coproporphyrins are a new class of signal molecules, which are transferred among a variety of bacteria in nature.

Figure 1
figure 1

Growth factor transfer network across different species. Growth factor supplied to uncultured Leucobacter sp. ASN212 from cultured Sphingopyxis sp. GF9 is shown as ASN212 growth factor. ASN212 growth factor not only stimulates proliferation of strain ASN212 but inhibits the growth of strain GF9 itself.

Results

Interspecies signaling between cultured strain GF9 and uncultured strain ASN212 or ASTN45

To address the nature of the growth stimulation, we isolated two previously uncultivated organisms that require the diffusible growth factors from strain GF9, namely strain ASN212 related to Leucobacter sp. within the phylum Actinobacteria and strain ASTN45 related to Bosea sp. within the class alpha-Proteobacteria from activated sludge. These strains did not show significant growth in NPB broth, a nutrient-rich medium that should suffice for bacterial cell growth, but the growth was clearly enhanced by the addition of strain GF9 supernatant (Supplementary Table 1, Supplementary Figures 1, 2a and 2b). The growth of strain ASN212 was stimulated not only by the supernatant of strain GF9 but also by those of different species, namely Sphingomonas macrogoltabidus, Sphingomonas sanguinis, Sphingomonas mali, Sphingobium chlorophenolica, Sphingopyxis terrae and Novosphingobium rosa, strongly suggesting that interspecies growth factor transfer takes place across a variety of species even at phylum level. Besides the ASN212 growth factor, strain GF9 secreted two other different types of growth factors, ASTN45 growth factor and AST4T growth factor (Figure 1 and Supplementary Table 1).

We first focused on the identification of ASN212 growth factor, because strain GF9 and strain ASN212 were different species at phylum level and ASN212 growth factor seemed to be relatively stable. In a two-compartment co-culture12 of strain GF9 and strain ASN212, permeable growth factors produced by strain GF9 in an outer chamber passed through the membrane and stimulated the growth of ASN212 in an inner chamber as shown in Figure 2. Strain ASN212 did not grow in a pure culture (ASN212 single culture), whereas its cell density has increased from 96 h in the co-culture with strain GF9 (ASN212 co-culture). Strain GF9 grew well till 96 h in a pure culture, however, its cell density has continuously decreased after 96 h (GF9 single culture). In the co-culture with strain ASN212, the growth profile of strain GF9 was very unique which indicated secondary log phase after first log phase followed by first stationary phase (GF9 co-culture), and the growth of strain GF9 after 96 h was approximately synchronized with that of strain ASN212 (ASN212 co-culture).

Figure 2
figure 2

Co-culture of Sphingopyxis sp. GF9 and Leucobacter sp. ASN212. Using Centriprep-50, NPB medium in the inner chamber was inoculated with strain ASN212 (ASN212 co-culture), and NPB medium in the outer chamber was inoculated with strain GF9 (GF9 co-culture). Single culture of strain GF9 or strain ASN212 was performed in the outer chamber without the inner chamber (GF9 single culture or ASN212 single culture). Each bacterial cell growth was monitored by the absorbance at 595 nm of aliquot from each chamber (n=3 biological replicates).

Isolation of ASN212 growth factors A, B, C, D, E and F

To identify ASN212 growth factors, we first tested the efficacy of strain GF9 supernatant to enhance the growth of strain ASN212 in NPB media. The supernatant induced significant growth of strain ASN212 with flocculation of the microbial cells, making it difficult to evaluate the efficacy in a dose-dependent manner (Supplementary Figure 1). A characteristic flocculation phenotype of strain ASN212 cells stimulated by ASN212 growth factors is shown as a magnified image of the flocks in Supplementary Figure 2c. The bioassay we established, however, allowed the easy and rapid detection of the active fractions by measuring OD595 at equivalent concentration (EC=dried fraction weight/culture volume of strain GF9) in a 48-well plate with a microplate reader.

Productivity of the growth factor was increased as much as around fivefold by optimizing the culture conditions of strain GF9 by using 5-l mini-jar fermentor (final conditions for 5-l mini-jar: tryptone peptone (Becton, Dickinson and Company, Sparks, MD, USA), 5.0 g l−1; yeast extract, 3.0 g l−1; 35 °C; 700 r.p.m.; 72 h). The culture conditions used in the 100-l stirred-tank bioreactor were determined based on the above conditions. The culture conditions in the bioreactor and the isolation procedure of ASN212 growth factors from the strain GF9 supernatant are described in detail in Experimental Procedure, and illustrated in Figure 3 and Supplementary Figure 3. The final yields of growth factors A–F were 0.3–3.0 mg from 210 l of the culture broth of strain GF9. The UV-visible spectra of these growth factors showed the Soret bands at 403 (A), 403 (B), 400 (C), 392 (D), 403 (E), 400 nm (F) and Q-bands at 550 to 570 nm, suggesting that these compounds are porphyrins or related molecules (Figure 4).

Figure 3
figure 3

The entire isolation procedure of ASN212 growth factors AF.

Figure 4
figure 4

Structures of ASN212 growth factors A, B, C, D, E and F isolated from strain GF9 supernatant. Growth factors AF were identified to be zinc coproporphyrin I (a), coproporphyrin I (b), zincphyrin (c), coproporphyrin III (d), zincmethylphyrin I (e) and zincmethylphyrin III (f), respectively. Growth factors E and F were structurally new compounds.

Structure identifications of growth factors A, B, C, D, E and F

Although these porphyrins were very slightly soluble in any solvents at the concentration suitable for NMR measurement, growth factors C and F were soluble in dimethyl sulfoxide (DMSO)-d6 and MeOH-d4, respectively.

To achieve structure determination of growth factor F, we first attempted to assign 1H and 13C NMR of growth factor C that seemed to be closely related to growth factor F. 1H and 13C NMR assignments of growth factors C and F were made from the 2D NMR analysis including COSY, ROESY, HSQC and HMBC (Supplementary Figures 4–6). Molecular formula of growth factor C was determined to be C36H36O8N4Zn by ESI-MS analysis, m/z 715.1766 [M−H]. The numbering of the carbon atoms is shown in both Figure 4 and Supplementary Figure 4a. 1H and 13C NMR assignments of growth factor C are indicated in Supplementary Table 2. 1H-1H COSY correlations showed δH 4.32 (31-H) and 3.16 (32-H) ppm. 1H-1H ROESY correlations were observed among characteristic meso-proton (δH 10.08 (5-H and 10-H), 10.35 (15-H), 10.05 (20-H)), methyl proton (δH 3.63 (21-H), 3.66 (71-H), 3.66 (121-H), 3.64 (181-H)) and side chain proton (δH 4.41 (31-H), 3.31 (32-H), 4.39 (81-H), 3.20 (82-H), 4.40 (131-H), 3.20 (132-H), 4.40 (171-H), 3.20 (172-H)) as shown in Supplementary Figures 4b and 5f. 1H-13C HSQC, 1H-13C HMBC analysis was also needed to assign 13C NMR of growth factor C whose HMBC correlations are shown in Supplementary Figures 4c and 5e. 1H-15N HMBC spectra of growth factor C indicated a broad singlet peak at δN 200 ppm correlated with meso-protons at 5-H, 10-H, 15-H and 20-H (Supplementary Figure 5g). Growth factor C was unambiguously identified by direct comparison with zincphyrin,13 which was synthesized from coproporphyrin III and Zn(OAc)2 as described in Experimental Procedure.

LC-ESI-MS analysis of growth factor F in negative mode showed quasi-molecular ion, m/z 729 [M−H] with m/z 731 [M+2−H], and 733 [M+4−H] suggesting that the compound was a zinc-containing porphyrin having stable isotopes,64Zn, 66Zn and 68Zn as in the case of zincphyrin (C). The molecular formula was deduced to be C37H38O8N4Zn from the high-resolution ESI-MS data, m/z 729.1924 [M−H] (Table 1). The difference between zincphyrin (C) and F in molecular formula was CH2 (14 mass units), which suggested that growth factor F was a methyl ester of zincphyrin (C). The singlet peak at δH 3.60 of growth factor F was assigned to the ester methyl protons. HSQC of growth factor F indicated that the carbon signal at δC 50.8 was the ester methyl carbon (Supplementary Figure 6d). The ester carbonyl C-33 at δC 174.3 was correlated with the methyl proton at δH 3.60 in the HMBC spectrum. The C-33 carbon was correlated with C-31 methylene proton at δH 4.41, which was correlated with C-2 carbon at δC 136.3. The C-2 carbon was correlated with the C-20 meso-proton at δH 10.08 as shown in Supplementary Figures 4f and 6e. The COSY, ROESY (Supplementary Figures 4e, 6c and 6f) and HSQC data (Supplementary Figure 6d) supported the assignment of growth factor F whose 1H and 13C NMR assignments are shown in Supplementary Table 2. 1H-15N HMBC spectra of growth factor F indicated a broad singlet peak at δN 193.5 ppm correlated with meso-protons at 5-H, 10-H, 15-H and 20-H (Supplementary Figure 6g). The structure of growth factor F was depicted in Figure 4, and we named this new compound ‘zincmethylphyrin III’. Growth factors A, B and D were identified as zinc coproporphyrin I,14 coproporphyrin I and coproporphyrin III, respectively, by comparing with their authentic samples in terms of HPLC retention time, UV-visible spectral pattern, ESI-MS and finally growth activities toward strain ASN212 (Figure 4,Table 1).

Table 1 Molecular formula of ASN212 growth factors AF and their minimum effective concentrations (MECs) on growth stimulation of Leucobacter sp. ASN212

Growth factor E was detected as the only one isomer of growth factor F, which indicated the identical molecular formula of C37H38O8N4Zn (Table 1). As in the case of relationship between zincphyrin (C) and zincmethylphyrin III (F), growth factor E was estimated to be the monomethyl ester of zinc coproporphyrin I (A). If growth factor E is a monomethyl ester of A, only one isomer is possible, because A has C4 rotational symmetry. All data of growth factor E coincided with those of the monomethyl ester of authentic zinc coproporphyrin I, which was synthesized by esterification of commercially available coproporphyrin I with TMS diazomethane followed by treatment with Zn(OAc)2 as described in Experimental Procedure. We named the structurally new growth factor E ‘zincmethylphyrin I’ (Figure 4).

Growth-stimulating activities of growth factors A, B, C, D, E and F

The minimum effective concentrations (MECs) of zincphyrin (C), coproporphyrin III (D), zincmethylphyrin III (F) and the minor growth factors, zinc coproporphyrin I (A), coproporphyrin I (B) and zincmethylphyrin I (E), were determined by measuring the dry weight of bacterial cells from a 70-ml culture of strain ASN212, which was stimulated by each individual growth factor (Table 1). The growth-stimulating activity of zincphyrin (C) was most evident with a MEC value of 14 pM followed by coproporphyrin III (D) whose MEC was 1.5 nM. Zincmethylphyrin III (F) was 343-fold less potent than zincphyrin (C), and its MEC was 4.8 nM. As zincmethylphyrin I (E) and zinc coproporphyrin I (A) were found to be less potent growth factors whose MECs were 9.6 and 20 nM, respectively, and the MEC of zinc-free coproporphyrin I (B) was 38 nM, a zinc ion and the relative position of the four propanoic acid groups in coproporphyrin III (D) seemed to be essential for the tremendous efficacy of zincphyrin (C) as a growth factor for an Actinobacteria, strain ASN212 (Table 1).

Strain GF9 produces a series of coproporphyrins and zinc coproporphyrins with variable flanking side chains that drastically affect the MEC values. Of the six growth factors identified, zincphyrin (C) was by far the most potent growth factor and the most abundant porphyrins secreted by strain GF9 (Experimental Procedure, Supplementary Figures 3c and d), whereas other coproporphyrins were capable of stimulating the growth of strain ASN212 at nanomolar concentrations under the standard laboratory conditions, demonstrating that all coproporphyrins represent a new class of growth factors for this Actinobacteria (Table 1).

Growth-stimulating activities of other porphyrins for strain ASN212

We then tested a panel of synthetic and commercial porphyrins including zinc coproporphyrin I, zincphyrin, zincmethylphyrin I, and commercially available hematin, hemin, hematoporphyrin, protoporphyrin IX, coproporphyrin I dihydrochloride, coproporphyrin III dihydrochloride, mesoporphyrin IX dihydrochloride, coproporphyrin I tetramethyl ester, coproporphyrin III tetramethyl ester, vitamin B12, chlorine e6, 5,10,15,20-tetraphenyl-21H,23H-porphine and 29H,31H phthalocyanine to explore the generality of porphyrin as growth factor for strain ASN212. Synthetic zinc coproporphyrin I, zincphyrin and zincmethylphyrin I showed exactly the same activities as natural growth factors A, C and E, respectively, while coproporphyrin I dihydrochloride and coproporphyrin III dihydrochloride stimulated the growth of strain ASN212 at comparable MECs with those of natural coproporphyrin I (B) and coproporphyrin III (D), respectively. Coproporphyrin III tetramethyl ester showed significant growth stimulation at 70 nM, which was 47 times higher MEC of coproporphyrin III (D), and hemin and hematin showed far less growth-promoting effects whose MECs were 1.2 and 2.4 μM, respectively (Table 1 and Supplementary Table 3). The rest of commercial porphyrins did not stimulate the growth of strain ASN212 even at the concentration of 1 mg ml−1.

Growth factors A, B, C, D, E and F exhibit self-toxicities against strain GF9

In addition to the above studies, we examined the pervasive effects of coproporphyrins on the growth of strains ASTN45, AST4T and GF9. Although both strains ASTN45 and AST4T were not affected, coproporphyrins secreted by strain GF9 significantly inhibited the growth of strain GF9 itself. The results are surprising and different from what we know about previously reported growth factors. It appeared that major growth factors, zincphyrin (C), coproporphyrin III (D) and zincmethylphyrin III (F), and minor growth factors, zincmethylphyrin I (E), zinc coproporphyrin I (A) and coproporphyrin I (B), completely inhibited the growth of strain GF9 at 10 × MEC to 15 × MEC; 0.1, 15, 48, 144, 293 and 573 nM, respectively, but the concentrations at which the growth of strain ASN212 was significantly stimulated and the order of efficacy as growth factor was exactly the same: C>D>F>E>A>B (Table 1). The half-maximal IC (IC50) of zincphyrin (C) against strain GF9 was 49 pM (Figure 5).

Figure 5
figure 5

Growth-inhibitory activity of zincphyrin (C) against Sphingopyxis sp. GF9. The growth-inhibitory effect was determined by a uniformly designed bioassay using 48-well microplates. Each plate was incubated at 28 °C for 24 h at 170 r.p.m., and the growth of strain GF9 was determined by measuring OD595 (n=3 biological replicates).

Discussion

Our present research has broken new ground by demonstrating that coproporphyrins produced by strain GF9 or commercially available porphyrins could have an impact on the growth of uncultured bacterial strain in laboratory conditions. To our knowledge, this is the first finding that coproporphyrins stimulate bacterial growth at the picomolar to nanomolar level. This research raises exciting possibilities for novel mechanisms on interactions of coproporphyrins with other bacteria that are very fastidious to cultivate or have yet to be cultured. Our findings indicate that not only this particular Sphingopyxis sp. GF9 but also other microbes may produce coproporphyrins, as the growth of Leucobacter sp. ASN212 is stimulated by the other microorganisms, namely, the family Sphingomonadaceae in the phylum Proteobacteria (Figure 1). The other striking feature of our study is that strain ASA212 in the phylum Actinobacteria required growth factor produced by an organism that is phylogenetically quite distant, indicating that interspecies growth factor transfer occurs transcending the boundaries of phylum level. As reported in previous work on the secretion of coproporphyrin III from Corynebacterium aurimucosum and Microbacterium oxydans15 and zincphyrin from Streptomyces sp.,13 not only Gram-negative but also various Gram-positive bacteria may secrete these coproporphyrin derivatives.

Commensalisms are well known in biology, but relations between different prokaryotic species are not well-understood and remain largely unclear. Initially, we supposed that the relation between strains GF9 and ASN212 is a kind of commensalism, as strain GF9 grows well independently. Thus, it seemed that strain GF9 altruistically provided coproporphyrins to the partner organism.

However, considering that these coproporphyrins were toxic to strain GF9 at picomolar to nanomolar levels, the uncultured strain ASN212 might help directly strain GF9 by up-taking or cleaning up the self-toxic coproporphyrins from the vicinity of the producing strain GF9. Flocculation of strain ASN212 observed after stimulating with these ASN212 growth factors might lead to reducing their toxicities against strain GF9. The co-culture experiments supported this possibility and implied that strains GF9 and ASN212 are dependent on each other for their growth and survival in the environments (Figures 1 and 2).

In this context, microbial commensalism is not the most appropriate wording to describe the relationship, and our findings suggest that a primitive obligate mutualism exists in the bacterial communities. More importantly, we could assume that coproporphyrins function as global signal molecules that sustain the complex microbial communities as a network system. In turn, it is very likely that a number of organisms can elude cultivation without receiving this secret elixir. We therefore propose here a general strategy using these porphyrins in lieu of siderophore5, 16 to access new microorganisms. This approach could expand drug discovery efforts, because secondary metabolites from the phylum Actinobacteria have provided new antibiotics, therapeutic agents and chemical probes to uncover the function of gene products related to various diseases.17 The global effect of these compounds in terms of microbial ecology, biochemistry and genetics are currently underway.

Experimental procedure

General experimental procedures

Water was Milli-Q water dispensed through 0.22-micron filter with 18.2 MΩ cm conductivity unless otherwise noted. Tryptone peptone (Becton, Dickinson and Company, Sparks, MD, USA), trimethylsilyldiazomethane (0.6 M in n-hexane, Tokyo Chemical Industry Co. Ltd., Tokyo, Japan) and triethylamine (Wako Pure Chemical Industries Co., Ltd (Wako), Osaka, Japan), and Centriprep YM-50 (Millipore Ireland B.V., Cork, Ireland) were purchased.

Bacterial strains and media

Sphingopyxis sp. GF9 and three uncultured strains Leucobacter sp. ASN212, Bosea sp. ASTN45, Catellibacterium nectariphilum AST4T were used in this study, all of which were stored in 25% glycerol with NPB medium consisting of 10.0 g tryptone peptone, 2.0 g yeast extract (Becton, Dickinson and Company), 1.0 g MgSO4·7H2O, 1.0 g KH2PO4, 5.0 g D-glucose in 1.0 l of Milli-Q H2O, pH 7.0 at −83 °C for further study.

Isolation of uncultured microbial strains ASN212 and ASTN45

Two previously uncultured microbial strains, ASN212 related to the genus Leucobacter within the phylum Actinobacteria and ASTN45 related to the genus Bosea within the class alpha-Proteobacteria, were isolated from activated sludges treating municipal wastewater and industrial effluent from a food company, respectively. Strain GF9 was cultivated in 100 ml of NPB medium and incubated for 3 days at 30 °C, and the resultant culture was centrifuged at 15 000 r.p.m. for 10 min. The supernatant was added to NPB medium at final concentration of 10%. This medium (NPBGF9) was used as an isolation medium for uncultured microbes requiring growth factors. An aliquot of activated sludge sample diluted to 10−4 with sterilized water was inoculated on a 1.5% agar plate. After incubation at 30 °C for 4 days, colonies that emerged on the agar plates were picked and isolated. The requirement for supernatant of strain GF9 was verified by comparing growth between the NPBGF9 agar plate and NPB agar plate. As a result, strains ASN212 and ASTN45 were obtained as two microbial strains indicating significant differences between growth on NPBGF9 and NPB agar plates or in NPB liquid media with and without GF9 supernatant (Supplementary Table 1, Supplementary Figures 1 and 2).

Co-culture of Sphingopyxis sp. strain GF9 and Leucobacter sp. strain ASN212

A dialyzing co-culture of strain GF9 and ASN212 was performed as previously described.12 Briefly, using a Centriprep YM-50 sterilized at 105 °C for 10 min, strain GF9 was inoculated into 5 ml of NPB medium in the outer chamber, and the test microbial strain ASN212 was inoculated into the inner chamber containing 5 ml of NPB medium. For each, initial OD595 was 0.01. The filter unit was incubated for 9 days at 30 °C with shaking at 160 r.p.m. The pure liquid culture from a single cell as a colony of strain GF9 or strain ASN212 was performed in a Centriprep YM-50 without the inner chamber. Aliquots (200 μl) from each chamber were withdrawn at 0, 48, 96, 144, 168, 184, 191 and 206 h, and OD595 of each sample was measured to monitor the growth of strain GF9 or strain ASN212.

Cultivation of strain GF9 in 100-l stirred-tank bioreactor

Strain GF9 was cultivated in a 100-l stirred-tank bioreactor (MARUBISHI MPF-100 l, BE Marubishi, Tokyo, Japan) at a laboratory of Graduate School of Engineering, Hokkaido University, Japan. The bioreactor was filled with 70 l of modified NPB media; differences were the amount of tryptone peptone (5 g l−1) in reverse osmosis water (RO-44P-B, Tohzai Chemical, Osaka, Japan) instead of Milli-Q water, being based on the culture conditions optimized by 5-l mini jar fermenter as described in Results. The medium was then sterilized by keeping the bioreactor in an autoclave mode for 15 min at 121 °C in 15 lbs. After autoclaving, the bioreactor was allowed to cool and 0.06% antifoam SI (Antifoam SI, Wako) suspension was added to reduce air bubble formation during the culture. The bacterial inoculum was prepared in three steps. Twenty microliters of strain GF9 stock solution were inoculated into 2.0 ml of NPB medium in culture tube, and incubated at 30 °C, 170 r.p.m. for 24 h. One milliliter of the culture was inoculated into a 100 ml of NPB medium in a 300-ml baffled Erlenmeyer flask, and cultured under the above conditions. Likewise, each 5-ml aliquot from the second preculture was inoculated in two 2-l baffled Erlenmeyer flasks containing 500 ml of NPB medium, which was allowed to culture under the same conditions for 48 h. The resultant 700 ml of the GF9 culture was poured into 70 l of NPB media and allowed to grow at 35 °C and 500 r.p.m. for 78 h. The bioreactor was aerated at a constant airflow of 1 vvm (air vol. flow/unit of liquid vol. of medium/min). Samples from the bioreactor were withdrawn at intervals of 10, 22, 27, 48, 60, 70 and 78 h, and OD (OD595 or OD660) was measured to monitor the growth of strain GF9. We made three batches of 100-l culture to obtain 210 l of a culture broth. The extraction and isolation of ASN212 growth factors AF were achieved as follows.

Extraction and isolation of ASN212 growth factors A–F

The 210 l of GF9 culture broth were centrifuged for 20 min at 10 000 g, and the supernatant (160 l) was extracted with the same volume of n-BuOH four times. The residual mixture was then transferred into a separatory funnel to collect the aqueous layer. The aqueous layer was concentrated in vacuo to give 900 g of dried material and subjected to MeOH precipitation by adding 2 l of MeOH (three times). The whole solution was filtrated through a filter paper (ADVANTEC, ø 125 mm, Advantec Toyo Roshi, Tokyo, Japan) to afford a MeOH-soluble part. The MeOH-soluble fraction was further concentrated in vacuo to give 540 g of the residue, which was applied to 10 l of a Diaion HP-20 (Mitsubishi Kasei, Tokyo, Japan) column. The column was eluted successively with water, 50% MeOH and MeOH, and the active fraction, which was determined by the bioassay described in the next section, was eluted with MeOH. The active eluate was concentrated under reduced pressure to give 25 g of a solid material, which was re-dissolved in 20 ml of MeOH and applied to a Sephadex LH-20 (2 l, GE Healthcare Bio-Sciences, Uppsala, Sweden) column packed with MeOH-H2O (8:2). The LH-20 column chromatography eluting with the same solvent system afforded the active fraction, which was concentrated in vacuo to give 125 mg of a dark-reddish solid. The solid was subjected to preparative HPLC (Mightysil RP-18 GP Aqua 20ø × 250 mm, 5 μm, Kanto Chemical, Tokyo, Japan, MeCN (0.1% AcOH)/H2O (0.1% AcOH), 53:47) to give six dark-reddish solids (ca. 20 mg in total). The active samples were finally purified by using an analytical HPLC column (Mightysil RP-18 GP Aqua 4.6ø × 250 mm, 5 μm, Kanto Chemical, MeCN (0.1% AcOH)/H2O (0.1% AcOH), 53:47) to yield six growth factors AF; 0.8 mg of A, 0.3 mg of B, 3.0 mg of C, 1.2 mg of D, 0.8 mg of E and 2.0 mg of F, respectively.

Bioassay for growth-stimulating activity of chromatographic fractions

Growth activities of strain GF9 supernatant, its extractive fractions and individual chromatographic fractions for strain ASN212 were tested in a uniformly designed bioassay. Each sample dried with a centrifugal vaporizer (EYELA CVE-200D, Tokyo, Japan) was reconstituted to equivalent concentration (EC=dried fraction weight/culture volume of strain GF9) with H2O. These experiments were performed utilizing standard 48-well micro-titer culture plate and 100 μl of each sample reconstituted to EC was added to each well followed by inoculation of 300 μl of NPB-ASN212, a mix of 20 μl of strain ASN212 stock solution and 18 ml of NPB medium. Equivalent concentration of strain GF9 supernatant and NPB medium were used as positive and negative controls, respectively. Strain GF9 supernatant and each sample were sterilized by filtration (0.2 μm Cellulose Acetate, DISMIC-13CP, Advantec Toyo Roshi) unless otherwise noted. The culture plates were incubated at 170 r.p.m. and 28 °C for 48 h in an incubator. Bacterial cell growth of strain ASN212 was monitored by OD measurement at 595 nm. To confirm the results, each assay was replicated at least three times.

NMR and ESI-MS measurements

NMR spectra of zincmethylphyrin III (F) in MeOH-d4 were measured with a JEOL JNM-ECA600 II spectrometer using an UltraCool probe (JEOL, Tokyo, Japan) for 1H, 13C, 1H-1H COSY, HSQC, HMBC and a JNM-ECZR500 spectrometer using a Royal probe for ROESY and 1H-15N HMBC. NMR spectra of zincphyrin (C) in DMSO-d6 were measured with a Bruker AMX-500 (Bruker, Billerica, MA, USA). Chemical shift was reported in δ ppm using tetramethylsilane as the internal standard, and coupling constants (J) were given in hertz. LC-ESI-MS and ESI-MS spectra were recorded on LTQ-Orbitrap XL (Thermo Fisher Scientific, Waltham, MA, USA) with or without a Paradigm MS2 (Michrom BioResources, Auburn, CA, USA) equipped with an InertSustain C18 column (GL Science, Tokyo, Japan).

Synthesis of zinc coproporphyrin I and its identification as growth factor A

Zinc coproporphyrin I was synthesized by a previously described method.14 Briefly, coproporphyrin I dihydrochloride (10.0 mg, 13.7 μmol) was dissolved in 4.1 ml of DMSO and mixed with an aqueous solution of Zn(OAc)2·2H2O (3.1 mg, 14.1 μmol) in 0.70 ml. The incorporation of Zn2+ into coproporphyrin I was confirmed by changes in its UV-visible spectrum and color. The reaction mixture was extracted by a solution of equal volumes of 10 mM AcOH and n-BuOH. Removal of the solvent from the organic layer under reduced pressure yielded 7.2 mg of zinc coproporphyrin I. The compound was identified as growth factor A by HPLC, UV-visible spectral pattern, color, ESI-MS and growth-promoting activity (Table 1 and Supplementary Table 3).

Synthesis of zincphyrin and its identification as growth factor C

Coproporphyrin III dihydrochloride (2.0 mg, 2.8 μmol) was dissolved in 0.81 ml of DMSO and mixed with 0.12 ml of an aqueous Zn(OAc)2·2H2O solution (0.61 mg, 2.8 μmol). The incorporation of Zn2+ into coproporphyrin III was confirmed by changes in the UV-visible spectrum and color. The reaction mixture was extracted by using an equal volume mixture of 10 mM AcOH and n-BuOH. The n-BuOH extract was evaporated in vacuo to yield 1.6 mg of a dark reddish compound reported as zincphyrin.13 Growth factor C was identified as zincphyrin by HPLC, UV-visible spectral pattern, color, ESI-MS, 1H and 13C NMR chemical shifts, and growth-promoting activity (Table 1 and Supplementary Table 3).

Synthesis of zincmethylphyrin I and its identification as growth factor E

Coproporphyrin I dihydrochloride (10.0 mg, 13.7 μmol) was dissolved in a mixed solution of 22.9 μl (1 eq.) of trimethylsilyldiazomethane (ca. 0.6 M in n-hexane) and 1.9 μl of triethylamine (1 eq.) in 400 μl of a mixture of hexane and MeOH (1:1). The resultant solution was stirred for 24 h at room temperature, until maximum consumption of the starting material was observed on TLC and analytical HPLC. The reaction mixture was evaporated to dryness and the crude methyl ester was dissolved in 4.1 ml of DMSO and mixed with 0.7 ml of an aqueous solution of Zn(OAc)2·2H2O (3.1 mg, 14.1 μmol). The incorporation of Zn2+ into the crude methyl ester was confirmed by changes in the UV-visible spectrum and color. The reaction mixture was extracted with an equal volume mixture of 10 mM aqueous AcOH and n-BuOH. The compound designated as zincmethylphyrin I was recovered from the organic layer and purified by HPLC. Growth factor E was identified as zincmethylphyrin I by HPLC, UV-visible spectral pattern, color, ESI-MS, and growth-promoting activity for ASN212 (Table 1 and Supplementary Table 3).

Porphyrin-mediated growth induction of strain ASN212

Synthetic porphyrins including zinc coproporphyrin I (A), zincphyrin (C), zincmethylphyrin I (E) and 13 different commercial porphyrins were tested for growth of strain ASN212 in liquid culture. Commercial porphyrins used were hematin (Alfa Aesar, Lancashire, UK), hemin (Sigma-Aldrich, St. Louis, MO, USA), hematoporphyrin (Wako), protoporphyrin IX (Sigma-Aldrich), coproporphyrin I dihydrochloride (Sigma-Aldrich), coproporphyrin III dihydrochloride (Strem Chemicals, Newburyport, MA, USA), mesoporphyrin IX dihydrochloride (Sigma-Aldrich), coproporphyrin I tetramethyl ester (Wako), coproporphyrin III tetramethyl ester (Sigma-Aldrich), vitamin B12 (Sigma-Aldrich), chlorine e6 (Frontier Scientific, Inc., Logan, UT, USA), 5,10,15,20-tetraphenyl-21H,23H-porphine (Sigma-Aldrich) and 29H,31H phthalocyanine (Sigma-Aldrich) (Table 1 and Supplementary Table 3).

MECs of growth factors A–F and other porphyrins

To determine the MECs of growth factors A, B, C, D, E, F and synthetic or commercial porphyrins, each compound stocked as 0.1% DMSO solution was mixed with 70 ml of NPB medium in a 500-ml K-1 flask (K-Techno, Toyama, Japan) adjusting it to the final concentrations in a range from 0.01 ng ml−1 to 5 μg ml−1. In the autoclaved liquid culture medium containing each respective concentration of porphyrins, 100 μl of the stock solution of strain ASN212 was inoculated. All flasks were incubated at 28 °C for 2 days at 80 r.p.m. The bacterial cells of strain ASN212 were collected on a pre-dried filter paper (ADVANTEC 4A, ø 90 mm, Advantec Toyo Roshi) by vacuum filtration, and the filtrate was removed after 5–6 min. The residual solid and filter paper were washed with 5 ml of H2O under reduced pressure and dried at 60 °C in a drying oven to reach a constant weight. The dry weight of residual solid was calculated by subtracting the constant weight of filter paper before use from that of the residual solid and filter paper. To convert the dry weight of residual solid into a concentration in the media, the weight of the residual solid was divided by 70 ml to give an exact concentration of dry cell weight shown as mg ml−1. The 0.1% DMSO solution was used for negative control instead of a 0.1% stock solution of growth factor. The MEC was determined by paired t-test (P<0.05) for comparison of the dry cell weights with and without growth factor (n=3 biological replicates).

Growth-inhibitory activities of ASN212 growth factors A–F against strain GF9

The growth-inhibitory activities of growth factors AF against strain GF9 were measured by a uniformly designed bioassay using 48-well micro-titer plates. The concentrations of each growth factor were adjusted to equivalent concentration (EC=final weight of each growth factor isolated/culture volume of strain GF9), and sequential concentrations of 0.5 × MEC to 20 × MEC with H2O. To each well containing 100 μl of each sample, 300 μl of the NPB-GF9 solution freshly prepared from NPB media (18 ml) and strain GF9 stock solution (20 μl) were added. The 0.1% DMSO aqueous solution was used as a negative control instead of each sample. Each growth factor was sterilized by filtration (0.2 μm Cellulose Acetate, DISMIC-13CP, Advantec Toyo Roshi) unless otherwise noted. Each plate was incubated at 28 °C for 24 h at 170 r.p.m. in an incubator. The growth of strain GF9 was monitored by OD at 595 nm. To confirm the result, each assay was replicated at least three times. The IC50 value of each growth factor was calculated using a GraFit 7-IC50 practice software (Erithacus Software Ltd., West Sussex, UK).